Vericel Corp Cash and Equivalents

Quick Answer

Vericel Corp reported Cash and Equivalents of $100.09 million for fiscal year 2025.

Vericel Corp Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $100.09M +34.3%
2024 $74.52M +7.9%
2023 $69.09M +35.3%
2022 $51.07M -25.3%
2021 $68.33M +103.2%
2020 $33.62M +25.0%
2019 $26.89M +47.0%
2018 $18.29M +126.9%
2013 $8.06M -40.9%
2012 $13.64M +146.6%
2011 $5.53M -82.3%
2010 $31.25M +121.3%
2010 $14.12M -16.9%
2009 $17.00M +3.1%
2008 $16.49M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $100.40M +87.0% +24.7%
June 30, 2025 $80.53M +60.1% +9.6%
March 31, 2025 $73.49M +16.8% -1.4%
December 31, 2024 $74.52M +7.9% +38.8%
September 30, 2024 $53.68M -11.2% +6.7%
June 30, 2024 $50.29M +16.9% -20.1%
March 31, 2024 $62.94M +1.8% -8.9%
December 31, 2023 $69.09M +35.3% +14.2%
  • Vericel Corp showed an increase of +34.3% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2008–2025 period, Vericel Corp’s cash and equivalents has grown by 506.9% (from $16.49 million to $100.09 million).
  • The most recent figure is from Vericel Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment